# Nurix Therapeutics, Inc.: Form 8-K, filed Jun 17, 2024

- Company: [Nurix Therapeutics, Inc.](/companies/nrix.md) (CIK 1549595)
- Form: 8-K
- Filed: 2024-06-17
- Accepted by EDGAR: Jun 17, 2024, 07:02 ET
- Period: 2024-06-16
- Accession: 0001549595-24-000086
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1549595/000154959524000086/nrix-20240616.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1549595/000154959524000086/

## Items reported

- Item 7.01: Regulation FD disclosure
- Item 8.01: Other events
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1549595/000154959524000086/nrix-20240616.htm

Filed Jun 17, 2024.
Source: SEC EDGAR, the filing index for accession 0001549595-24-000086. Last ingested by Listed: Nov 5, 2026, 13:59 ET. No prices; not investment advice.